EODData

MEMBERSHIP REGISTER LOG IN

FRA, 4AB: AbbVie Inc

03 Sep 2025
LAST:

181.4

CHANGE:
 2.00		OPEN:
181.4		HIGH:
181.4		ASK:
0.0		VOLUME:
217
CHG(%):
1.11		PREV:
179.4		LOW:
181.4		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 25181.4181.4181.4181.4217
02 Sep 25179.4179.4179.4179.4217
01 Sep 25179.4179.4178.6178.6217
29 Aug 25177.8179.6177.2179.6101
28 Aug 25177.6177.6177.6177.65
27 Aug 25179.4180.0179.4179.4129
26 Aug 25177.6177.6177.6177.6375
25 Aug 25179.0180.4178.2179.0375
22 Aug 25180.6180.6180.4180.447
21 Aug 25180.4181.0180.4181.013

COMPANY PROFILE

Name:AbbVie Inc
About:AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Sector:Healthcare
Address:1 North Waukegan Road, North Chicago, IL, United States, 60064-6400
Website:https://www.abbvie.com
ISIN:US00287Y1091
LEI:FR5LCKFTG8054YNNRU85

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:101.34
DivYield:0.04
Div/Share:6.47
Price to Book:50.25
Price to Sales:5.51
EBITDA:28.074B
Shares:1.767B
Market Cap:320.454B

TECHNICAL INDICATORS

MA5:179.32
MA10:179.40
MA20:176.59
MA50:168.25
MA100:165.50
MA200:171.84
STO9:100.00
STO14:100.00
RSI14:67.02
MTM14:5.60
ROC14:0.03
ATR:1.69
Week High:181.40
Week Low:177.20
Month High:181.40
Month Low:167.10
Year High:201.65
Year Low:145.96

RECENT DIVIDENDS

Date Amount
15 Jul 2025$1.41
15 Apr 2025$1.41
15 Jan 2025$1.41
15 Oct 2024$1.33
15 Jul 2024$1.33
12 Apr 2024$1.33
12 Jan 2024$1.33
12 Oct 2023$1.27
13 Jul 2023$1.27
13 Apr 2023$1.27